Abandonment of High-Dose Chemotherapy/Hematopoietic Cell Transplants for Breast Cancer Following Negative Trial Results

OBJECTIVE: In 1999, three randomized controlled trials concluded that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HDC/HCT) is no better than conventional chemotherapy for women with breast cancer. This study documents the impact of the trials on use of HDC/...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Howard, David H, Kenline, Carolyn, Lazarus, Hillard M, LeMaistre, Charles F, Maziarz, Richard T, McCarthy, Philip L, Parsons, Susan K, Szwajcer, David, Douglas Rizzo, James, Majhail, Navneet S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2011
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393031/
https://ncbi.nlm.nih.gov/pubmed/21790588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1475-6773.2011.01296.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak